(R)-4-(Iodomethyl)oxazolidin-2-one, 95.0%, 5g

8-Chloro-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one, 95+%, 1g

13-Oxa-6,7-dithia-2,11-diazapentadecanoic acid, 3,10-bis(methoxycarbonyl)-14,14-dimethyl-12-oxo-, 1,1-dimethylethyl ester, (3S,10S)-, 10g

4-Oxazolecarboxamide, 2-(2-chloro-6-fluorophenyl)-5-[[4-(4-morpholinylcarbonyl)phenyl]amino]-, 250mg

2,4-Dibromo-1-(trifluoromethoxy)benzene, 98%, 10g

1-(4-Fluoro-2-nitrophenyl)piperidine-3-carboxylic acid, 1g

1-Ethyl-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline, 97%, 100mg

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, 98%, 25g

3-Hydroxy-5-nitrobenzotrifluoride, 97.0%, 5g

1-(3-Methoxy-4-nitrophenyl)piperidin-4-ol, 95.0%, 250mg

4-[(E)-2-(4-Methoxyphenyl)ethenyl]-1-methylpyridin-1-ium iodide, 96.0%, 250mg

Orange IV sodium salt (C.I. 13080), 25 g

Methyl 3-amino-2-hydroxybenzoate, 97.0%, 5g